Patents by Inventor Peter Niepoth
Peter Niepoth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240358646Abstract: A process for preparing a polymer-coated hard shell capsule can be performed. The hard shell capsule has a body and a cap. In the closed state the cap overlaps the body either in a pre-locked state or in a final-locked state. The hard shell capsule is provided in the pre-locked state and coated with a coating solution, suspension or dispersion that has at least one polymer; at least one glidant; at least one emulsifier; optionally at least one plasticizer; optionally at least one biologically active ingredient; and optionally at least one additive, different from the above. The process is used to obtain a coated, preferably only at the outer surface, hard shell capsule in the pre-locked state, wherein the coating solution, suspension or dispersion has a surface tension of at most 38 mN/m. The polymer-coated hard shell capsule obtained from the process is used for immediate, delayed or sustained release.Type: ApplicationFiled: May 19, 2022Publication date: October 31, 2024Applicant: Evonik Operations GmbHInventors: Hans Bär, Felix Hofmann, Steven Smith, Peter Niepoth, Rima Jaber, Bettina Hölzer
-
Publication number: 20240189236Abstract: A composition suitable as coating or binding agent for pharmaceutically, nutraceutically or cosmetically active ingredients includes: a) at least one (meth)acrylate copolymer a), including polymerized units of 5-25% by weight of methacrylic acid and 75-95% by weight of C1-4-alkylesters of methacrylic acid and/or C1-4-alkylesters of acrylic acid, and b) 1-25% by weight, based on the total weight of at least one (meth)acrylate copolymer a), of an alkali or ammonium salt of a saturated aliphatic monocarboxylic acid having 10 to 30 carbon atoms, and c) or d) or both c) and d) c) 2-25% by weight, based on the total weight of a), of at least one compound selected from glyceryl tristearate, hydroxypropyl methylcellulose, glyceryl behenate, and glyceryl monostearate and/or d) 25-90% by weight, based on the total weight of a), of at least one selected from talc, rice hulls in powder form, magnesium stearate, corn starch, and microcrystalline cellulose.Type: ApplicationFiled: July 7, 2022Publication date: June 13, 2024Applicant: Evonik Operations GmbHInventors: Erna ROTH, Andrea ENGEL, Peter NIEPOTH, Lisa GÜTTLER, Andreas KLOSENDORF
-
Publication number: 20220326199Abstract: A method of unambiguous identification and authentication of products for the purpose of better recognition of product forgeries and controlling product piracy, including applying to/into the product an identification substance admixture which contains paramagnetic phases or identifying a product which contains an identification substance admixture containing paramagnetic phases and has an ESR fingerprint spectrum that permits unambiguous identification of the product. Such an ESR fingerprint spectrum is easily measurable, but can be copied or forged only with difficulty. The method relates to an individualizable “femto tag” for femto ledgers and forms an important interface for what are known as “Internet of Things” (IOT).Type: ApplicationFiled: June 4, 2020Publication date: October 13, 2022Applicant: Evonik Operations GmbHInventors: Norbert WINDHAB, Kevin BURTON, Paul Joseph SPENCER, Jessica MÜLLER-ALBERS, Andrea ENGEL, Peter NIEPOTH, Rüdiger ALEXOWSKY, Julia LYUBINA, Christoph BRÜCHER, Carsten DENTLER, Andreas KARAU
-
Publication number: 20220287345Abstract: The invention provides preparations comprising at least one polyunsaturated fatty acid salt for use in enhancing the solubility in aqueous media for a pharmaceutical or nutraceutical active ingredient in comparison to the pharmaceutical or nutraceutical active ingredient alone by at least 100%, preferably at least 300%. Moreover, a method for preparing a pharmaceutical or nutraceutical dosage form comprising at least one polyunsaturated fatty acid salt and at least one pharmaceutical or nutraceutical active ingredient is disclosed.Type: ApplicationFiled: August 7, 2020Publication date: September 15, 2022Applicant: Evonik Operations GmbHInventors: Ashish GUHA, Sonam SINGH, Shraddha JOSHI, Peter NIEPOTH, Kathrin NOLLENBERGER, Prajakta SURVE, Priyanka HAKSAR
-
Patent number: 11084908Abstract: A process prepares a polymer powder, with a D50 particle size from 40 to 200 ?m and a Hausner factor of 1.25 or less, by freeze drying and subsequent loosening up of an aqueous polymer dispersion containing 15 to 50% by weight of a polymer. The polymer is polymerized from 10 to 30% by weight of methyl methacrylate, 50 to 70% by weight of methyl acrylate, and 5 to 15% by weight of methacrylic acid.Type: GrantFiled: August 7, 2019Date of Patent: August 10, 2021Assignee: Evonik Operations GmbHInventors: Peter Niepoth, Verena Melk, Andrea Engel
-
Publication number: 20210238369Abstract: A process prepares a polymer powder, with a D50 particle size from 40 to 200 ?m and a Hausner factor of 1.25 or less, by freeze drying and subsequent loosening up of an aqueous polymer dispersion containing 15 to 50% by weight of a polymer. The polymer is polymerized from 10 to 30% by weight of methyl methacrylate, 50 to 70% by weight of methyl acrylate, and 5 to 15% by weight of methacrylic acid.Type: ApplicationFiled: August 7, 2019Publication date: August 5, 2021Applicant: Evonik Operations GmbHInventors: Peter Niepoth, Verena Melk, Andrea Engel
-
Patent number: 10165988Abstract: The invention relates to a device with a sensor arrangement, which is able to detect magnetic or magnetized oral administration forms after oral take-up, moreover tracks the dissolution thereof via the reduction or disappearance of the magnetic field of the oral administration form, and with a log function, which records a subjective evaluation on the part of the human wearer of the sensor arrangement during or after the oral take-up.Type: GrantFiled: June 6, 2014Date of Patent: January 1, 2019Assignee: EVONIK ROEHM GmbHInventors: Benedikt Hartwig, Peter Niepoth, Hans-Joachim Stiller, Steffen Junginger
-
Patent number: 9696279Abstract: The subject matter of the invention is a detector system for detecting magnetic bodies in the human organism, which comprises at least two sensor assemblies, wherein each sensor assembly has one, two or three anisotropic magnetic resistance sensors, of which the axes of weak magnetization point in different directions in pairs, and each sensor assembly has a spacing of 0.5 to 50 cm from the sensor assembly or the other sensor assemblies, and at least two sensor assemblies are tilted at an angle of 0 to 45° with respect to one another, and in addition a method for detecting the magnetic flux produced by a magnetic body in the human organism, and the use of the detector system according to the invention for detecting swallowed magnetic bodies and the disintegration of the same in the digestive system.Type: GrantFiled: January 9, 2012Date of Patent: July 4, 2017Assignee: Evonik Roehm GmbHInventors: Benedikt Hartwig, Peter Niepoth, Steffen Junginger, Hans-Joachim Stiller, Norbert Windhab, Gerhard Geipel
-
Publication number: 20160135759Abstract: The invention relates to a device with a sensor arrangement, which is able to detect magnetic or magnetized oral administration forms after oral take-up, moreover tracks the dissolution thereof via the reduction or disappearance of the magnetic field of the oral administration form, and with a log function, which records a subjective evaluation on the part of the human wearer of the sensor arrangement during or after the oral take-up.Type: ApplicationFiled: June 6, 2014Publication date: May 19, 2016Applicant: EVONIK ROEHM GmbHInventors: Benedikt HARTWIG, Peter NIEPOTH, Hans-Joachim STILLER, Steffen JUNGINGER
-
Publication number: 20150008914Abstract: The subject matter of the invention is a detector system for detecting magnetic bodies in the human organism, which comprises at least two sensor assemblies, wherein each sensor assembly has one, two or three anisotropic magnetic resistance sensors, of which the axes of weak magnetisation point in different directions in pairs, and each sensor assembly has a spacing of 0.5 to 50 cm from the sensor assembly or the other sensor assemblies, and at least two sensor assemblies are tilted at an angle of 0 to 45° with respect to one another, and in addition a method for detecting the magnetic flux produced by a magnetic body in the human organism, and the use of the detector system according to the invention for detecting swallowed magnetic bodies and the disintegration of the same in the digestive system.Type: ApplicationFiled: January 9, 2012Publication date: January 8, 2015Applicant: EVONIK ROEHM GMBHInventors: Benedikt Hartwig, Peter Niepoth, Steffen Junginger, Hans-Joachim Stiller, Norbert Windhab, Gerhard Geipel